Quarterly Results Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Jun'26
Mar'26
Dec'25
Sep'25
Jun'25
Mar'25
Dec'24
Net Sales
805.18
747.65
767.64
806.10
721.99
646.89
561.79
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
805.18
747.65
767.64
806.10
721.99
646.89
561.79
Raw Material Cost
274.66
245.40
290.10
248.99
216.17
223.76
183.08
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
5.11
3.91
5.12
5.68
5.76
5.26
4.63
Selling and Distribution Expenses
326.67
320.79
276.57
344.40
324.95
297.94
324.12
Other Expenses
1.98
1.70
1.72
0.17
3.45
2.96
0.50
Total Expenditure (Excl Depreciation)
626.20
587.09
589.00
600.81
581.36
556.56
516.80
Operating Profit (PBDIT) excl Other Income
179
160.6
178.6
205.3
140.6
90.3
45
Other Income
6.93
2.96
-39.82
1,054.13
-1.56
2.90
-61.37
Operating Profit (PBDIT)
246.77
241.08
107.48
1,254.61
187.39
171.00
-6.17
Interest
5.11
3.91
5.12
5.68
5.76
5.26
4.63
Exceptional Items
-0.22
0.00
0.62
0.00
0.00
-0.40
0.40
Gross Profit (PBDT)
530.52
502.25
477.54
557.11
505.82
423.13
378.71
Depreciation
83.11
83.11
72.72
72.72
77.77
77.77
53.87
Profit Before Tax
158.33
154.06
30.26
1,176.21
103.86
87.56
-64.27
Tax
34.39
44.93
27.37
206.00
39.20
7.48
-50.90
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
168.90
126.80
16.82
984.48
108.59
109.16
23.65
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
168.90
126.80
16.82
984.48
108.59
109.16
23.65
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
-20.63
-5.41
-7.50
-4.85
-7.04
-2.46
-1.34
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
148.28
121.39
9.32
979.63
101.55
106.70
22.31
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
6,834.69
7,239.77
7,103.14
7,128.41
6,120.97
6,494.92
6,383.54
Earnings per share (EPS)
0.09
0.07
0.01
0.51
0.06
0.06
0.01
Diluted Earnings per share
0.09
0.07
0.01
0.51
0.06
0.06
0.01
Operating Profit Margin (Excl OI)
19.46%
20.73%
9.72%
15.85%
15.4%
13.96%
0.24%
Gross Profit Margin
29.98%
31.72%
13.42%
154.94%
25.16%
25.56%
-1.85%
PAT Margin
20.98%
16.96%
2.19%
122.13%
15.04%
16.88%
4.21%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - QoQ
Net Sales
QoQ Growth in quarter ended Jun 2026 is 7.69% vs -2.59% in Mar 2026
Consolidate Net Profit
QoQ Growth in quarter ended Jun 2026 is 22.16% vs 1,205.38% in Mar 2026
Operating Profit (PBDIT) excl Other Income
QoQ Growth in quarter ended Jun 2026 is 0.71% vs 61.64% in Mar 2026
Interest
QoQ Growth in quarter ended Jun 2026 is 30.77% vs -23.53% in Mar 2026
Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Jun 2026 has fallen from Mar 2026
Compare Quarterly Results Of Tonghua Dongbao Pharmaceutical Co., Ltd. With
Figures in Million
Consolidate Quarterly Results
Change(CNY)
Change(%)
Net Sales
805.18
0
805.18
Other Operating Income
0.00
0.00
0.00
Total Operating income
805.18
0
805.18
Raw Material Cost
274.66
0
274.66
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
5.11
0
5.11
Selling and Distribution Expenses
326.67
0
326.67
Other Expenses
1.98
0.00
1.98
Total Expenditure (Excl Depreciation)
626.20
0
626.20
Operating Profit (PBDIT) excl Other Income
178.98
0.00
178.98
Other Income
6.93
0
6.93
Operating Profit (PBDIT)
246.77
0
246.77
Interest
5.11
0
5.11
Exceptional Items
-0.22
0
-0.22
Gross Profit (PBDT)
530.52
0
530.52
Depreciation
83.11
0
83.11
Profit Before Tax
158.33
0
158.33
Tax
34.39
0
34.39
Provisions and contingencies
0
0
0.00
Profit After Tax
168.90
0
168.90
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
168.90
0
168.90
Share in Profit of Associates
0
0
0.00
Minority Interest
-20.63
0
-20.63
Other related items
0.00
0.00
0.00
Consolidated Net Profit
148.28
0
148.28
Equity Capital
0
0
0.00
Face Value
1.00
0
0.00
Reserves
6,834.69
0
6,834.69
Earnings per share (EPS)
0.09
0
0.09
Diluted Earnings per share
0.09
0
0.09
Operating Profit Margin (Excl OI)
19.46%
0%
0.00
19.46%
Gross Profit Margin
29.98%
0%
0.00
29.98%
PAT Margin
20.98%
0%
0.00
20.98%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 80.52 Million
in Jun 2026Figures in Million
QoQ Growth in quarter ended Jun 2026 is 7.69% vs -2.59% in Mar 2026
YoY Growth in quarter ended Jun 2026 is 11.52% vs 385.87% in Jun 2025
Quarterly - Consolidate Net Profit
Consolidate Net Profit 14.83 Million
in Jun 2026Figures in Million
QoQ Growth in quarter ended Jun 2026 is 22.16% vs 1,205.38% in Mar 2026
YoY Growth in quarter ended Jun 2026 is 46.11% vs 122.80% in Jun 2025
Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 23.98 Million
in Jun 2026Figures in Million
QoQ Growth in quarter ended Jun 2026 is 0.71% vs 61.64% in Mar 2026
YoY Growth in quarter ended Jun 2026 is 26.88% vs 171.97% in Jun 2025
Quarterly - Interest
Interest 0.51 Million
in Jun 2026Figures in Million
QoQ Growth in quarter ended Jun 2026 is 30.77% vs -23.53% in Mar 2026
YoY Growth in quarter ended Jun 2026 is -12.07% vs 100.00% in Jun 2025
Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 19.46%
in Jun 2026Figures in %
QoQ Growth in quarter ended Jun 2026 has fallen from Mar 2026
YoY Growth in quarter ended Jun 2026 has improved from Jun 2025
Footer loading
